SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
View ORCID ProfileGloria D. Chechet, View ORCID ProfileJacob K.P. Kwaga, Joseph Yahaya, View ORCID ProfileAnnette MacLeod, View ORCID ProfileWalt E. Adamson
doi: https://doi.org/10.1101/2021.12.21.21268166
Gloria D. Chechet
1Department of Biochemistry, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Zaria, Nigeria
2Africa Centre of Excellence for Neglected Tropical Diseases and Forensic Biotechnology, Ahmadu Bello University, Zaria, Nigeria
Jacob K.P. Kwaga
2Africa Centre of Excellence for Neglected Tropical Diseases and Forensic Biotechnology, Ahmadu Bello University, Zaria, Nigeria
3Department of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria
Joseph Yahaya
1Department of Biochemistry, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Zaria, Nigeria
2Africa Centre of Excellence for Neglected Tropical Diseases and Forensic Biotechnology, Ahmadu Bello University, Zaria, Nigeria
Annette MacLeod
4Institute of Biodiversity, Life Sciences, and Animal Health, University of Glasgow, United Kingdom
Walt E. Adamson
4Institute of Biodiversity, Life Sciences, and Animal Health, University of Glasgow, United Kingdom

Article usage
Posted December 27, 2021.
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
Gloria D. Chechet, Jacob K.P. Kwaga, Joseph Yahaya, Annette MacLeod, Walt E. Adamson
medRxiv 2021.12.21.21268166; doi: https://doi.org/10.1101/2021.12.21.21268166
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
Gloria D. Chechet, Jacob K.P. Kwaga, Joseph Yahaya, Annette MacLeod, Walt E. Adamson
medRxiv 2021.12.21.21268166; doi: https://doi.org/10.1101/2021.12.21.21268166
Subject Area
Subject Areas
- Addiction Medicine (271)
- Allergy and Immunology (559)
- Anesthesia (135)
- Cardiovascular Medicine (1777)
- Dermatology (173)
- Emergency Medicine (316)
- Epidemiology (10827)
- Gastroenterology (595)
- Genetic and Genomic Medicine (2964)
- Geriatric Medicine (289)
- Health Economics (534)
- Health Informatics (1936)
- Health Policy (836)
- Hematology (295)
- HIV/AIDS (634)
- Medical Education (300)
- Medical Ethics (89)
- Nephrology (325)
- Neurology (2816)
- Nursing (152)
- Nutrition (433)
- Oncology (1475)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (259)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (382)
- Pediatrics (869)
- Primary Care Research (341)
- Public and Global Health (5390)
- Radiology and Imaging (1019)
- Respiratory Medicine (729)
- Rheumatology (330)
- Sports Medicine (279)
- Surgery (329)
- Toxicology (48)
- Transplantation (150)
- Urology (127)